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Axonal death disrupts functional connectivity of
neural circuits and is a critical feature of many
neurodegenerative disorders. Pathological axon
degeneration often occurs independently of known
programmed death pathways, but the underlying
molecular mechanisms remain largely unknown.
Using traumatic injury as a model, we systematically
investigate mitogen-activated protein kinase (MAPK)
families and delineate a MAPK cascade that repre-
sents the early degenerative response to axonal
injury. The adaptor protein Sarm1 is required for
activation of this MAPK cascade, and this Sarm1-
MAPK pathway disrupts axonal energy homeo-
stasis, leading to ATP depletion before physical
breakdown of damaged axons. The protective cy-
toNmnat1/Wlds protein inhibits activation of this
MAPK cascade. Further, MKK4, a key component
in the Sarm1-MAPK pathway, is antagonized by
AKT signaling, which modulates the degenerative
response by limiting activation of downstream JNK
signaling. Our results reveal a regulatory mechanism
that integrates distinct signals to instruct patholog-
ical axon degeneration.
INTRODUCTION
Axons connect neurons with their innervating targets, forming
the intricate neural circuits underlying perception, motility,
cognition, and memory. However, the enormous distance axons
can span (e.g., over a meter for certain axons in humans) creates
a challenge for maintaining their structural and functional
integrity. In fact, axonal death has been observed as a key path-
ological feature in many neurodegenerative disorders including
traumatic injury, Alzheimer’s disease, Parkinson’s disease,
glaucoma, multiple sclerosis, and amyotrophic lateral sclerosis
(Conforti et al., 2014; Wang et al., 2012).A common form of pathological axonal death is observed in
segments distal to a site of traumatic injury, a process known
as Wallerian degeneration. The discovery of the Wallerian
Degeneration Slow mouse (Wlds) and characterization of the
Wlds protein, whose gain-of-function can dramatically prolong
axonal survival after injury, has suggested that death of injured
axons is not simply due to loss of trophic support from neuronal
cell bodies, but is instead triggered by an intrinsic signal(s) in
axons. The Wlds protein can suppress axon degeneration in
many neurodegeneration models besides traumatic injury (Con-
forti et al., 2014; Wang et al., 2012), suggesting that a common
mechanismmight regulate axonal death in different neurodegen-
erative conditions.
Despite morphological similarities to cells undergoing
apoptosis, including membrane blebbing and cytoskeletal frag-
mentation, axon degeneration under pathological conditions
often does not involve the classic apoptotic pathway. For
instance, genetic deletion of apoptotic regulators like BAX and
caspases has no effect on Wallerian degeneration (Simon
et al., 2012; Whitmore et al., 2003). In addition, at least during
traumatic injury, axon degeneration also appears independent
of the necroptotic pathway, since treatment with necroptosis
inhibitors or lentiviral-shRNA knockdown of signaling compo-
nents of necroptosis pathway like RIP3 andMLKL do not protect
axons (data not shown). Therefore, axonal death in traumatic
injury, as well as in neurodegeneration more broadly, likely
represents a yet-to-be-characterized death program critical for
human diseases. In-depth understanding of this degeneration
program should illuminate neurodegenerative diseases and
reveal novel therapeutic targets to battle them.
Our colleagues and we recently showed that loss-of-
function of the adaptor protein Sarm1 significantly delays degen-
eration of injured axons (Gerdts et al., 2013; Osterloh et al.,
2012). Despite this breakthrough, signaling components in
the Sarm1-mediated degenerative response are largely un-
known. Previous studies have described roles for Sarm1 or its
C. elegans ortholog tir-1 in neural development (Chen et al.,
2011; Chuang and Bargmann, 2005), stress responses (Couil-
lault et al., 2004; Kurz et al., 2007), and non-apoptotic cell death
(Blum et al., 2012). While the identity of signaling componentsCell 160, 161–176, January 15, 2015 ª2015 Elsevier Inc. 161
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varies in different settings, a MAPK cascade downstream of
Sarm1/tir-1 has been observed in each case, suggesting poten-
tial conservation of the Sarm1-MAPK signaling axis. In addition,
genetic deletion of the mouse MAPK kinase kinase (MAPKKK)
member DLK transiently delayed, though to a significantly lesser
extent than in Wlds mice, the degeneration of injured axons in
sciatic nerves in vivo and in cultured sensory neurons in vitro
(Miller et al., 2009; Shin et al., 2012), and protection in vitro
was also seen with a pharmacological inhibitor of MAPKs of
the JNK family (Chen et al., 2012; Miller et al., 2009). Weak pro-
tection of injured axons was also reported with deletion of the
DLK homolog Wallenda in Drosophila in some neurons (Miller
et al., 2009), though not others (Osterloh et al., 2012; Xiong
and Collins, 2012).
These observations prompted us to systematically investigate
MAPK family members, and we delineate a MAPK cascade
that is central in axon degeneration under pathological condi-
tions. This cascade represents the early degenerative response,
and Sarm1 is required for its activation after injury. Activation of
the Sarm1-MAPK pathway in turn disrupts local energy homeo-
stasis in injured axons, leading to ATP depletion before activa-
tion of calpains and breakdown of axonal structures. We find
that a cytosolic version of Nmnat1 (nicotinamide mononucleo-
tide adenylyltransferase 1, an enzyme in the NAD+ synthesis
pathway), whichmimics the functional moiety of theWlds protein
(Sasaki et al., 2009), inhibits activation of this MAPK pathway.
Furthermore, MKK4, a central component in the pathway, is
antagonized by AKT signaling, which modulates the early
degenerative response by limiting activation of downstream
JNKs. Our results reveal that distinct signals can converge
onto a central MAPK pathway that triggers local energy deficit
to promote pathological axon degeneration—a regulatory mech-
anism with potentially broad implications in neurodegenerative
disorders.
RESULTS
Fluorescence-Labeling Approach to Examine Axons
Undergoing Degeneration
To facilitate in vivo analysis of injury-induced axon degeneration,
we established an approach to examine the axons of retinal
ganglion cells (RGCs) undergoing degeneration in mouse
optic nerves. RGCs were sparsely labeled with the TdTomato
fluorescent protein via intravitreal delivery of adeno-associated
virus 2 (AAV2). Degeneration of TdTomato-positive RGC axons
was visualized at different time points following traumaticFigure 1. MEKK4/MLK2/DLK Function as the Predominant MAPKKKs
(A to C) MEKK4/MLK2/DLK regulate degeneration of injured sensory axons. Cultu
of MEKK4, MLK2 and DLK, individually or in combination. The efficiency of lentivir
from each condition (A). Axon degeneration at indicated time points following axo
(C), n = 3 for each condition.
(D and E) MEKK4/MLK2/DLK regulate degeneration of injured RGC axons in vivo
virus together with either Cre/scrambled-shRNA or Cre/MEKK4-shRNA. Degener
optic nerve crush (D), and degeneration was quantified (E), n = 4 for each condit
(F and G) MEKK4/MLK2/DLK regulate degeneration of injured cortical axons. Cul
with lentivirus expressing Cre together with scrambled-shRNA or MEKK4-shRNAs
by immunostaining (F), and degeneration was quantified (G), n = 3 for each cond
See also Figure S3 and Table S1.injury (optic nerve crush). Across experiments, 70% to 80%
of TdTomato-positive axons showed large swellings and/or
fragmentation and were scored as degenerated 3 days after
injury, and all axons had fragmented by 6 days (Figures S1A
and S1B). This approach gave equivalent results to electron
microscopic analysis (Figures S1C and S1D), i.e., about 80%
of all RGC axons underwent demyelination and/or cytoskeletal
destruction at 3 days, with complete breakdown of axonal struc-
tures by 6 days.
To validate this approach further, we examined the cytosolic
version of Nmnat1 (cytoNmnat1). As expected, in a transgenic
mouse line expressing cytoNmnat1 driven by the prion protein
promoter (PrP) (Sasaki et al., 2009), most TdTomato-positive
axons remained intact 6 days after injury (Figures S1A and
S1B). Transduction of wild-type axons with a virus expressing
TdTomato-P2A-cytoNmnat1 (TdTomato and cytoNmnat1 pro-
teins linked by a porcine teschovirus-derived self-cleaving 2A
peptide) similarly resulted in robust protection, with over 60%
of TdTomato-positive axons being intact at 6 days (Figures
S1A and S1B). Of note, the protection level observed with TdTo-
mato-P2A-cytoNmnat1 was modestly weaker than that in cy-
toNmnat1-transgenic mice, even though the level of cytoNmnat1
protein expressed by AAV2 was higher than by the transgene
(Figure S1E). We attribute this to the fact that, in TdTomato-
P2A-cytoNmnat1 optic nerves, unlabeled RGC axons (>99% of
all axons) still degenerated normally as shown by electronmicro-
scopy (Figures S1C and S1D). There was profound activation of
microglia and astrocytes in TdTomato-P2A-cytoNmnat1 nerves,
but not in cytoNmnat1-transgenic nerves (Figure S1F), and it
seems possible that this inflammatory response might second-
arily influence axonal survival.
Further confirming the effectiveness of our approach, we
found that RGC axons of wild-type mice transduced with
TdTomato/Sarm1-shRNA (TdTomato together with a specific
shRNA targeting Sarm1) virus were highly resistant to degenera-
tion after nerve injury, in contrast to those transduced with con-
trol TdTomato/scrambled-shRNA virus (Figures S2D and S2E),
consistent with the fact that Sarm1 mRNA is expressed in
RGCs (Figure S2A) and degeneration of injured RGC axons
was largely blocked in Sarm1/ mice (Figures S2B and S2C).
Finally, degeneration of traumatically-injured axons depends
on calpain activation as it can be delayed by expression of the
endogenous calpain inhibitor calpastatin (Yang et al., 2013).
Confirming this, RGC axons of CAPNS1flox/flox mice transduced
with a TdTomato-P2A-Cre virus, which results in disruption of
both calpain-1 and calpain-2 activity through deletion of theirin Axon Degeneration Following Traumatic Injury
res of embryonic DRG neurons were subjected to lentiviral-shRNA knockdown
al-shRNAs was examined by immunoblot analysis of axonal proteins harvested
tomy was visualized by immunostaining (B), and degeneration was quantified
. RGCs of the mice with indicated genotypes were transduced with TdTomato
ation of TdTomato-positive axons was visualized at indicated time points after
ion.
tures of embryonic cortical neurons with indicated genotypes were transduced
. Axon degeneration at indicated time points following axotomy was visualized
ition. Values are presented as mean ± SEM; *p < 0.01.
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common small subunit (Tan et al., 2006), showed significantly
delayed degeneration compared to those of wild-type mice (Fig-
ures S2F and S2G). Together, our results show that this labeling
approach can provide effective cell-autonomousmanipulation of
signaling components involved in axon degeneration.
A Central MAPK Pathway in Axon Degeneration after
Traumatic Injury
Sarm1 was recently shown to regulate axon degeneration after
traumatic injury (Gerdts et al., 2013; Osterloh et al., 2012). As
mentioned, in other biological processes Sarm1 and its ortholog
tir-1 were linked to MAPK signaling, and prior genetic analyses
implicated the MAPKKK member DLK as a weak regulator in
degeneration of injured axons (Miller et al., 2009; Osterloh
et al., 2012; Shin et al., 2012), prompting us to investigate the
function of MAPK families more systematically.
There are 23 members of the MAPKKK family in mouse. Using
cultured sensory neurons, we found that the highly specific in-
hibitor PLX-4720 for three MAPKKKs, A-raf, B-raf, and C-raf,
did not offer protection after axotomy (data not shown). We
therefore performed lentiviral-shRNA knockdown screening of
the remaining 20 MAPKKK members (Table S1) and observed
that knockdown of each of three MAPKKK members, MEKK4,
MLK2, and DLK, in sensory axons partially protected (Figures
1A to 1C). Moreover, MEKK4/MLK2/DLK function additively, as
knockdown of any two produced a stronger phenotype (data
not shown), and knockdown of all three resulted in the strongest
protection, with about 60% of axons intact 48 hr after axotomy
(Figures 1A to 1C). In parallel, we examined expression of
mRNAs for the 23 MAPKKKmembers in adult mouse retina (Fig-
ure S3A). Many show no or very low expression (e.g.,MAP3K15),
but a few are strongly expressed (e.g., B-raf). Importantly,
MEKK4, MLK2, and DLK mRNAs are all expressed in RGCs. In
functional analyses, we found that RGC axons in DLKflox/flox
mice transduced by viral delivery of Cre together with a control
scrambled-shRNA (Cre/scrambled-shRNA) showed a modest
delay of degeneration compared to DLKflox/+ mice 3 days, but
not 6 days, after injury (Figures 1D and 1E), in line with the tran-
sient protection of injured axons inmouse sciatic nerve afterDLK
deletion (Shin et al., 2012). Greater protection was seen after
further knockdown of MEKK4 in RGC axons of DLKflox/flox mice
with a Cre/MEKK4-shRNA virus, and evenmore withMLK2 dele-
tion through delivery of that virus into DLKflox/flox; MLK2/mice,
with 50% of TdTomato-positive axons remaining intact 6 days
after injury (Figures 1D and 1E). Although we cannot rule out
that other MAPKKKsmight exert a minor role, our results identifyFigure 2. MKK4 Functions as the Predominant MAPKK Assisted by MK
(A to C) MKK4 regulates degeneration of injured sensory axons. Cultures of emb
Efficiency of lentiviral-shRNAs was examined by immunoblot analysis of axonal p
with the two most efficient lentiviral-shRNAs was visualized by immunostaining a
n = 3 for each condition.
(D and E) MKK4 functions with MKK7 to regulate degeneration of injured RGC ax
Cre/scrambled-shRNA or Cre/MKK7-shRNA virus. Ai14 represents the Rosa26-
visualized at indicated time points after optic nerve crush (D), and degeneration
(F and G) MKK4/MKK7 regulate degeneration of injured cortical axons. Cultures
lentivirus expressing Cre together with scrambled-shRNA or MKK7-shRNA. Axo
immunostaining (F), and degeneration was quantified (G), n = 3 for each conditio
See also Figure S3 and Table S1.MEKK4/MLK2/DLK as the predominant MAPKKKs regulating
this degeneration process.
We next explored the seven members of MAPK kinase
(MAPKK) family. Inhibition of MEK1/MEK2 with the highly spe-
cific inhibitor PD-0325901 failed to protect sensory axons after
injury in vitro (data not shown). We therefore screened lentivi-
ral-shRNAs against the other five MAPKK members (Table S1).
Knockdown of MKK4 (also known as SEK1) led to strong protec-
tion of injured sensory axons, i.e., with either of the two most
efficient shRNAs, axon degeneration was almost completely
suppressed at 24 hr, and about 50% of injured axons persisted
even at 48 hr (Figures 2A to 2C). In parallel, we examined expres-
sion of six MAPKK members in adult mouse retina, and found
that mRNAs for all six, including MKK4, are expressed in
RGCs (Figure S3B). To determine the function of MKK4
in vivo, RGC axons of MKK4flox/flox mice were transduced with
a Cre/scrambled-shRNA virus. TdTomato-positive axons were
dramatically protected against degeneration compared to those
in MKK4flox/+ mice 3 days after injury (Figures 2D and 2E). How-
ever, RGC axons in MKK4flox/flox mice still exhibited significant
degeneration at 6 days, raising the possibility that otherMAPKKs
might contribute. Indeed, further knockdown of MKK7 in RGC
axons of MKK4flox/flox mice using a Cre/MKK7-shRNA virus
led to significant enhancement of protection, i.e., over 40% of
TdTomato-positive axons were intact at 6 days (Figures 2D
and 2E). Of note, transduction of RGC axons of MKK4flox/+
mice with the Cre/MKK7-shRNA virus did not offer protection
(Figures 2D and 2E), and shRNA knockdown of MKK3 or
MKK6 failed to enhance protection in MKK4flox/flox mice (data
not shown). These results identify MKK4 as the predominant
MAPKK in axon degeneration after injury, with MKK7 exerting
a moderate redundant function.
MKK4 activates MAPK members of the JNK and p38 families,
whereas MKK7 only activates JNK family members (Weston and
Davis, 2007). mRNAs of all three JNKs and two p38s (p38alpha
and p38delta) are expressed in RGCs in adult mouse retina
(Figure S4A). In vitro treatment of injured RGC axons with a
JNK inhibitor but not a p38 inhibitor delayed degeneration (Fig-
ures S4C and S4D), consistent with previous reports (Chen
et al., 2012; Miller et al., 2009). As well, in the lentiviral-shRNA
screening of 13 MAPK family members (Table S1), knockdown
of JNK3 significantly protected sensory axons in vitro, i.e.,
degeneration was strongly suppressed 24 hr after axotomy
with either of the two most efficient shRNAs, and a sizable frac-
tion of injured axons still remained intact at 48 hr with the most
efficient shRNA (Figures 3A to 3C). Consistent with the in vitroK7 in Axon Degeneration Following Traumatic Injury
ryonic DRG neurons were subjected to lentiviral-shRNA knockdown of MKK4.
roteins harvested from each condition (A). Degeneration of axons transduced
t indicated time points after axotomy (B), and degeneration was quantified (C),
ons in vivo. RGCs of the mice with indicated genotypes were transduced with
CAG-LSL-TdTomato reporter. Degeneration of TdTomato-positive axons was
was quantified (E), n = 4 for each condition.
of embryonic cortical neurons with indicated genotypes were transduced with
n degeneration at indicated time points following axotomy was visualized by
n. Values are presented as mean ± SEM; *p < 0.01.
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results, degeneration of RGC axons was significantly delayed
6 days after injury in JNK3/ mice, and the protection level
was greater in JNK2/; JNK3/mice, while there was no effect
in JNK2/ mice alone (Figures S4E and S4F). Further, shRNA-
knockdown of JNK1 in wild-type RGC axons inhibited degener-
ation after injury (Figures 3D and 3E). More importantly, survival
of RGC axons in JNK2/; JNK3/ mice was enhanced by
shRNA-knockdown of JNK1, with about 60% of TdTomato-pos-
itive axons being intact at 6 days (Figures 3D and 3E). Therefore,
JNK1/JNK2/JNK3 function to regulate the degeneration of
injured axons, with JNK1 and JNK3 playing predominant roles.
MAPK signaling can be modulated by various scaffold pro-
teins, including the JIPs (JNK-interacting proteins) (Morrison
and Davis, 2003). mRNAs of three JIPs are expressed in adult
mouse RGCs (Figure S4B). Knockdown of JIP3 in wild-type
RGCs with a TdTomato/JIP3-shRNA virus protected their axons
at 3 days, though not 6 days, after injury (Figures S4G and S4H,
data not shown), whereas shRNA-knockdown of JIP1 or JIP2 did
not (data not shown), showing specific involvement of JIP3 in this
process.
Thus, using sensory neurons and RGCs as models, we delin-
eate a MAPK cascade comprising three MAPKKKs (MEKK4/
MLK2/DLK), two MAPKKs (MKK4/MKK7), three MAPKs (JNK1/
JNK2/JNK3), and the scaffold protein JIP3, as a central pathway
in axon degeneration after traumatic injury. This MAPK cascade
is also critical for the degeneration of injured cortical axons, as
combinatorial depletion of MEKK4/MLK2/DLK (Figures 1F and
1G), MKK4/MKK7 (Figures 2F and 2G), or JNK1/JNK2/JNK3
(Figures 3F and 3G) in cultured cortical neurons all strongly pro-
tected against injury, with the protective level comparable to that
in Sarm1/ cortical neurons (Osterloh et al., 2012).
TheMAPK Cascade Functions Downstream of Sarm1 as
the Early Degenerative Response to Axonal Injury
We next examined activation of this MAPK pathway after axonal
injury. Ser257/Thr261 phosphorylation of MKK4, which reflects
activity of upstream MAPKKKs, was evident as little as 5 min af-
ter optic nerve injury. MKK4 activation peaked between 15 to
30 min, then returned to baseline between 2 to 4 hr (Figures 4A
and S5A). This signaling represents the early degenerative
response, occurring days before physical breakdown of axons,
as assessed by proteolysis of cytoskeletal components starting
around 48 hr (e.g., a-internexin, Figure 4A).
MKK4 activation in injured optic nerves was specific to RGC
axons. When we transduced RGCs of MKK4flox/flox mice with a
saturating amount of Cre virus, which depleted MKK4 proteinFigure 3. JNK1 and JNK3 Function as the Predominant MAPKs Assist
(A to C) JNK3 regulates degeneration of injured sensory axons. Cultures of emb
Efficiency of lentiviral-shRNAs was examined by immunoblot analysis of axonal p
with the two most efficient lentiviral-shRNAs was visualized by immunostaining a
n = 3 for each condition.
(D and E) JNK1 and JNK3 function as the predominant MAPKs in regulating deg
notypes were transduced with TdTomato/scrambled-shRNA or TdTomato/JNK
indicated time points after optic nerve crush (D), and degeneration was quantifie
(F and G) JNK1/JNK2/JNK3 regulate degeneration of injured cortical axons. Cult
with lentivirus expressing scrambled-shRNA or JNK1-shRNA. Axon degeneration
(F), and degeneration was quantified (G), n = 3 for each condition. Values are pre
See also Figure S4 and Table S1.in over 90% of RGCs (Figure S5C) and decreased total MKK4
protein in optic nerves, this in turn eliminated MKK4 phosphory-
lation on Ser257/Thr261 in injured nerves (Figures 4B and S5B).
Deletion of MKK4 in RGC axons also largely diminished activa-
tion of downstream JNKs (Figure 4B). To determine the physio-
logical role of MKK4 phosphorylation on Ser257/Thr261 in
degeneration, we depleted endogenous MKK4 protein in RGCs
of MKK4flox/flox mice with Cre, and concurrently delivered into
these cells wild-type MKK4 or the MKK4(S257A/T261A) mutant.
After nerve injury, RGC axons of MKK4flox/flox mice transduced
with the Cre-P2A-MKK4(WT) virus degenerated normally (Fig-
ures 7E and 7F). In contrast, RGC axons transduced with the
Cre-P2A-MKK4(S257A/T261A) virus exhibited strong reduction
of degeneration at 3 days (Figures S5D and S5E) similar to that
seen inMKK4flox/flox mice transduced with the Cre virus (Figures
2D and 2E), showing that MKK4(S257A/T261A) failed to rescue
the function of endogenous MKK4. Moreover, MKK4(S257A/
T261A) had a dominant-negative effect, since RGC axons of
wild-type mice transduced with the Cre-P2A-MKK4(S257A/
T261A) virus showed delayed degeneration 3 days after injury
(Figures S5D and S5E).
We also studied MKK4 activation in an in vitro degeneration
model, which allows us to obtain preparations of axonal pro-
teins excluding neuronal cell bodies and non-neuronal cells,
and therefore to focus on axon-specific events (Yang et al.,
2013). Similar to our in vivo data, MKK4 phosphorylation on
Ser257/Thr261 occurred during the early degenerative response
in vitro, peaking around 10 to 15 min after axotomy (Figures 6A
and 6B), but hours before proteolysis of cytoskeletal proteins
(e.g., aII-spectrin). In addition, treatment of RGC axons in vitro
with the JNK inhibitor during the first 1 hr after injury was suffi-
cient to suppress degeneration (data not shown), similar to a pre-
vious observation implying an early role of JNK signaling in the
degeneration of injured sensory axons (Miller et al., 2009).
Supporting the hypothesis of an evolutionarily conserved
Sarm1-MAPK signaling axis, early activation ofMKK4 and down-
stream JNKs in injured optic nerves was abolished in Sarm1/
mice (Figures 4C and S5B). Similarly, MKK4 phosphorylation
on Ser257/Thr261 was absent in Sarm1/ sensory axons in
the in vitro model (Figure 6H). To further determine the genetic
interaction between Sarm1 and the MAPK cascade, we exam-
ined additivity of the protective effects afforded by depletion
of Sarm1 or MKK4/MKK7. Combinatorial depletion of MKK4/
MKK7 in sensory axons resulted in strong protection until 48 hr
after axotomy, but most injured axons eventually degenerated
at 96 hr (Figures 4E and 4F). While shRNA knockdown ofed by JNK2 in Axon Degeneration after Traumatic Injury
ryonic DRG neurons were subjected to lentiviral-shRNA knockdown of JNK3.
roteins harvested from each condition (A). Degeneration of axons transduced
t indicated time points after axotomy (B), and degeneration was quantified (C),
eneration of injured RGC axons in vivo. RGCs of the mice with indicated ge-
1-shRNA virus. Degeneration of TdTomato-positive axons was visualized at
d (E), n = 4 for each condition.
ures of embryonic cortical neurons with indicated genotypes were transduced
at indicated time points following axotomy was visualized by immunostaining
sented as mean ± SEM; *p < 0.01.
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Sarm1 gave rise to a similar protection, Sarm1-shRNA did not
further potentiate protection by MKK4/MKK7 depletion (Figures
4E and 4F). Similarly, though Sarm1/ sensory axons were
highly resistant to degeneration, the majority degenerated
96 hr after axotomy (Figures S5F and S5G). shRNA knockdown
of MKK4/MKK7 also strongly protected, but failed to further
extend survival of Sarm1/ axons. The non-additivity of protec-
tive effects implies that Sarm1 and the MAPK cascade reside in
the same genetic pathway.
Domain analyses of Sarm1 or its ortholog tir-1 have indicated
that the SAM domains mainly function in protein dimerization,
which enables the C-terminal TIR domain to activate down-
stream signaling. The N-terminal ARM domain exerts an auto-
inhibitory role, because Sarm1 or TIR-1 without the ARM domain
appears constitutively active (Chuang and Bargmann, 2005;
Gerdts et al., 2013). Consistent with this, expression of a
Sarm1 mutant lacking the N-terminal ARM domain led to axon
degeneration about 4 to 6 days after viral transduction (data
not shown). To control the pro-degenerative Sarm1 signal in a
temporally-defined manner, we fused the Sarm1 TIR-domain
to FKBP(F36V), which could be dimerized by the cell-permeable
chemical AP20187. Treatment of sensory neurons expressing
FKBP(F36V)-TIR with AP20187 induced degeneration of distal
axons (Figures 4G and 4H), which appears independent of the
apoptotic pathway since it was not affected by genetic deletion
of caspase-9 or overexpression of Bcl-xl (data not shown).
Importantly, axons of neurons expressing FKBP(F36V)-TIR
showed rapid MKK4 phosphorylation on Ser257/Thr261 in
response to AP20187 (Figures S5H and S5I), and their degener-
ation was largely blocked by combinatorial depletion of MKK4/
MKK7 or JNK1/JNK2/JNK3 (Figures 4I and 4J). Although care
must be taken in interpreting the effect of Sarm1 gain-of-func-
tion, especially as FKBP(F36V)-TIR dimerization also led to
atrophy and death of neuronal cell bodies similar to that
observed with constitutively-active Sarm1 (Gerdts et al., 2013;
Summers et al., 2014), the results nonetheless further support
the model that Sarm1 functions upstream of the MAPK cascade.
The axonal protective function of the Wlds protein has been
known for decades, but its underlying mechanism remains
elusive. To determine its relationship to MAPK signaling, we
examined activation of the pathway in cytoNmnat1-transgenic
mice. Early activation of MKK4 and downstream JNKs in injured
optic nerves in vivo was suppressed in these mice (Figures 4DFigure 4. Sarm1 Is Required for Activation of the MAPK Cascade as an
(A to D) Nerve samples were harvested at indicated time points after optic nerve
MAPK cascade represents an early response to axonal injury. (B) MKK4 functions
type orMKK4flox/flox mice were subjected to saturated transduction of Cre virus fo
MAPK cascade. (D) Activation of the MAPK cascade is suppressed by the cytoN
(E and F) Sarm1 and MKK4/MKK7 function in the same genetic pathway. Culture
expressing scrambled-shRNA or Sarm1-shRNA. Axon degeneration at indicate
degeneration was quantified (F), n = 3 for each condition.
(G and H) Induced dimerization of the Sarm1 TIR-domain causes axon degenera
FKBP(F36V) or FKBP(F36V)-TIR. Axon degeneration at 24 hr after treatment with
quantified (H), n = 3 for each condition.
(I and J) Axon degeneration induced by the Sarm1 TIR-domain requires the M
transduced with lentivirus expressing FKBP(F36V)-TIR. Axon degeneration at 24 h
Values are presented as mean ± SEM; *p < 0.01; n.s., not significant.
See also Figure S5.and S5B), and MKK4 phosphorylation on Ser257/Thr261 was
absent from their sensory axons after axonal injury in vitro (Fig-
ure 6I), suggesting that cytoNmnat1/Wlds might protect by inhib-
iting the MAPK pathway.
The Sarm1-MAPK Pathway Triggers Local Energy
Deficit Leading to Morphological Degeneration
Activation of the Sarm1-MAPK pathway occurs minutes after
injury, but hours or even days before breakdown of axonal struc-
tures, prompting us to explore the connection between these
processes. A previous study reported a decrease of ATP level
in injured axons that could be inhibited by the Wlds protein
(Wang et al., 2005), but the relevance of ATP depletion was ques-
tioned by other studies (Press and Milbrandt, 2008; Summers
et al., 2014). Of note, the original measurement of ATP levels
was carried out with axonal samples (Wang et al., 2005), but in
later studies was done with whole neuronal cultures including
cell bodies, and we reasoned that this difference might explain
the discrepancy. Taking advantage of our in vitro axonal enrich-
ment method and also a newly-devised luciferase-based ATP
measurement method (instead of classic HPLC), we followed
ATP levels exclusively in axons after injury. Consistent with the
original study (Wang et al., 2005), there was continuous deple-
tion of axonal ATP in injured sensory axons, which preceded pro-
teolysis of cytoskeletal proteins andmorphological degeneration
(Figures 5A and 5B, and data not shown). That study also
showed that ATP levels in axons could be rescued by metabolic
fuel such as methyl-pyruvate (a cell-permeable form of pyruvate)
provided prior to injury (Wang et al., 2005). We extended that
finding by treating injured axons with methyl-pyruvate 2 hr
post-axotomy, i.e., after the early activation of Sarm1-MAPK
pathway in this in vitro model (Figures 6A and 6B), and observed
that it could also significantly delay the ATPdepletion (Figure 5C).
Because calpain activation is responsible for proteolysis of
cytoskeletal components and physical breakdown of axonal
structures (Figures S2F and S2G) (Yang et al., 2013), we exam-
ined the relationship between this local energy deficit and cal-
pain activation. Methyl-pyruvate treatment, which delayed ATP
depletion, strongly suppressed calpain-mediated proteolysis of
cytoskeletal proteins (Figure 5D) as well as morphological
degeneration of injured axons (Figure 5E and Figure 5F). To
further confirm that calpains function downstream of ATP deple-
tion, we treated injured axons 2 hr post-axotomy with calpainEarly Response to Axonal Injury
crush for immunoblot analysis (two mice per time point). (A) Activation of the
as the predominant MAPKK for activation of downstream JNKs. RGCs of wild-
r 6 weeks prior to optic nerve crush. (C) Sarm1 is required for activation of the
mnat1 transgene.
s of sensory neurons with indicated genotypes were transduced with lentivirus
d time points following axotomy was visualized by immunostaining (E), and
tion. Cultures of sensory neurons were transduced with lentivirus expressing
0.5 mM AP20187 was visualized by immunostaining (G), and degeneration was
APK cascade. Cultures of sensory neurons with indicated genotypes were
r after treatment with 0.5 mMAP20187 was quantified, n = 3 for each condition.
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Figure 5. The Sarm1-MAPK Pathway Triggers an Axonal Energy Deficit Following Traumatic Injury
(A and B) Energy deficit precedes calpain activation in injured axons. Axonal ATP levels of cultured sensory neurons were measured at indicated time points after
axotomy (A, n = 6 for each condition), and in parallel, axonal proteins were harvested for immunoblot analysis (B).
(C to F) Energy deficit is causative to calpain activation andmorphological degeneration. Cultures of sensory neurons were provided with 10mMmethyl-pyruvate
as metabolic fuel 2 hr post-axotomy. At indicated time points, axonal ATP levels were measured (C, n = 6 for each condition), axonal proteins were harvested for
immunoblot analysis (D), axon degeneration was visualized by immunostaining (E), and the degeneration was quantified (F, n = 4 for each condition).
(G to I) Calpains function downstreamof axonal energy deficit. Cultures of sensory neuronswere treatedwith 10 mMcalpain inhibitor III (G, n = 6 for each condition)
or 5 mM EGTA (I, n = 6 for each condition) 2 hr post-axotomy, or were transduced with lentivirus expressing calpastatin (H, n = 4 for each condition). Axonal ATP
levels were measured at indicated time points.
(J to L) The Sarm1-MAPK pathway triggers local energy deficit following axonal injury. Axonal ATP levels of cultured sensory neurons with indicated genotypes
were measured at indicated time points after axotomy, n = 4 for each condition. Values are presented as mean ± SEM; *p < 0.01.
See also Figure S6.
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inhibitor III, which is relatively selective to calpains (Yang et al.,
2013), or transduced the neurons with lentivirus expressing the
endogenous specific calpain inhibitor calpastatin. Both methods
strongly inhibited calpain activation andmorphological degener-
ation (Yang et al., 2013), but neither ameliorated the energy
deficit in injured axons (Figure 5G and 5H). Similarly, treatment
of injured axons 2 hr post-axotomy with EGTA to chelate Ca2+
that is essential for calpain activation —a manipulation that
also protects axons (data not shown)—also failed to rescue
axonal ATP levels (Figure 5I). The results together argue that
the local energy deficit in axons precedes, and is causative to,
calpain activation and morphological degeneration after injury.
Importantly, the first detectable change of axonal ATP levels
occurred around 2 hr post-axotomy (e.g., Figure 1A), after the
early activation of the Sarm1-MAPK pathway (Figure 6A and
6B), and depletion of Sarm1, MKK4/MKK7, or JNK1/JNK2/
JNK3, which suppressed morphological degeneration as re-
ported above, all dramatically preserved ATP levels in injured
axons (Figure 5J to 5L), even better than methyl-pyruvate treat-
ment. The same was also true in sympathetic (i.e., superior cer-
vical ganglion) axons: injury triggered ATP depletion in these
axons that preceded proteolysis of cytoskeletal proteins and
morphological degeneration (data not shown); this energy deficit
was not affected by calpain inhibition (Figure S6A), but was
significantly delayed by deletion of Sarm1 (Figure S6B) or inhibi-
tion of JNKs (Figure S6C). Together, our results support the
model that the Sarm1-MAPK pathway triggers a local energy
deficit in injured axons, which leads to calpain activation and
morphological degeneration.
Pro-Degenerative Function of MKK4 Is Antagonized
by AKT
While studying the phosphorylation status of Sarm1-MAPK
components in injured axons, we unexpectedly found that
MKK4 was also phosphorylated on Ser78. This phosphorylation
increased significantly around 1 to 5 min after injury, even pre-
ceding phosphorylation on Ser257/Thr261 (Figures 6A and 6B).
The sequence surrounding Ser78 residue of mouse MKK4
is an authentic target for AKT, and phosphorylation of Ser78
can inhibit MKK4 activity (Park et al., 2002). Two selective
AKT inhibitors, i.e., the allosteric inhibitor MK-2206 and the
ATP-competitive inhibitor GDC-0068, both significantly reduced
MKK4 phosphorylation on Ser78 in axons after injury (Figure 6C),
though as expected from their distinct mechanisms, MK-2206
decreased while GDC-0068 increased AKT phosphorylation on
Thr308 andSer473, residues critical for AKT activation (Figure 6C
and data not shown). We noted that phosphorylation on Thr308
and Ser473 appeared constant in injured axons and only started
to decrease when degeneration began (Figures 6A and 6C).
However, there was enhanced interaction between AKT and
MKK4 in axons immediately after injury (Figure 6D), temporally
correlating with increased MKK4 phosphorylation on Ser78 (Fig-
ures 6A and 6B).
We explored how these two distinct phosphorylation events
regulate MKK4 activity toward downstream JNKs. MKK4 was
expressed in cultured cells with DLK (whose overexpression
is self-activating, and thus mimics activation of the MAPK
cascade) or myrAKT1 (a constitutively-active form of AKT1that mimics AKT signaling). As expected, DLK significantly
increased MKK4 phosphorylation on Ser257/Thr261, and myr-
AKT1 enhanced MKK4 phosphorylation on Ser78 (Figure 6E).
Notably, AKT-mediated Ser78 phosphorylation did not affect
the level of Ser257/Thr261 phosphorylation induced by DLK,
and vice versa. Moreover, when phospho-S257/T261-MKK4
was specifically enriched using the p-S257/T261-MKK4 anti-
body, Ser78 phosphorylation was retained in the immunoprecip-
itated sample (Figure 6E). The results suggest that the two
phosphorylation events are biochemically independent. Next,
MKK4 expressed with DLK or myrAKT1 was immunoaffinity
purified and subjected to a kinase assay using recombinant
JNK3(K55R) as the substrate. While MKK4 activated by DLK
had strong activity in phosphorylating JNK3, MKK4 expressed
with DLK and AKT1 together exhibited little activity, even though
the two samples had similar levels of Ser257/Thr261 phosphor-
ylation (Figure 6F). This Ser78 phosphorylation-mediated inhibi-
tion of MKK4 activity correlated with a decrease of direct interac-
tion betweenMKK4 and the JNK substrate in a protein pull-down
assay (Figure 6G), in line with the fact that a major JNK-binding
site of MKK4 is adjacent to the Ser78 residue (Ho et al., 2003).
The AKT-mediated inhibitory effects were abolished with the
MKK4(S78A) mutant protein (Figures 6F and 6G). These results
show that while Ser257/Thr261 phosphorylation of MKK4 acti-
vates its kinase activity toward JNK, Ser78 phosphorylation of
MKK4 can block its interaction with the JNK substrate.
Interestingly, unlike Ser257/Thr261 phosphorylation, MKK4
phosphorylation on Ser78 was not affected in injured sensory
axons from Sarm1/ (Figures 6H and S6D) or cytoNmnat1-
transgenic (Figures 6I and S6D) mice. Moreover, AKT inhibition
did not have a significant effect on MKK4 phosphorylation on
Ser257/Thr261 after injury (Figure 6C). The results suggest
that AKT signaling targets MKK4 in a Sarm1-independent
manner.
The finding that AKT-mediated Ser78 phosphorylation can
suppress Ser257/Thr261-phosphorylated MKK4 activity toward
JNKs raised the possibility that it might promote axonal survival.
Indeed, transient inhibition of AKT in the first 1 hr after injury
significantly accelerated degeneration of RGC axons in vitro
(Figure S6G and S7H). In vivo, MKK4 phosphorylation on
Ser78 was present in optic nerves and transiently increased after
injury (Figure 7A), and was dramatically reduced following dele-
tion of MKK4 in RGCs of MKK4flox/flox mice with the Cre virus
(Figure 7A). Supporting involvement of AKT signaling, mRNAs
of all three AKT members are expressed in RGCs (Figure 7B).
To determine its physiological relevance, we depleted endo-
genous MKK4 protein in RGCs of MKK4flox/flox mice with
Cre, and concurrently delivered either wild-type MKK4 or the
MKK4(S78A) mutant, which were expressed at levels compara-
ble to endogenous MKK4 both in cultured cells (Figure S6E) and
in optic nerves (Figure 7C). After nerve injury, MKK4flox/flox mice
transduced with the Cre-P2A-MKK4(WT) virus showed a similar
level of JNK activation as in wild-typemice, whereas those trans-
duced with the Cre-P2A-MKK4(S78A) virus exhibited signifi-
cantly stronger JNK activation (Figures 7C and 7D). In the latter
case, RGC axons underwent accelerated degeneration, i.e.,
while the vast majority of TdTomato-positive axons were intact
in wild-type mice or in the Cre-P2A-MKK4(WT) condition 48 hrCell 160, 161–176, January 15, 2015 ª2015 Elsevier Inc. 171
Figure 6. Sarm1-Independent Regulation of MKK4 by AKT Signaling in the Early Response to Axonal Injury
(A and B) Two temporally distinct MKK4 phosphorylation events in response to axonal injury. Axonal proteins of cultured sensory neurons were harvested at
indicated time points after axotomy for immunoblot analysis (A), and MKK4 phosphorylation on Ser78 or Ser257/Thr261 was quantified (B). Values are presented
as mean ± SD.
(C) Inhibition of AKT signaling abolishes MKK4 phosphorylation on Ser78 in injured axons. Cultures of sensory neurons were treated with 5 mM MK-
2206 or 5 mM GDC-0068 for 1 hr prior to axotomy. Axonal proteins harvested at indicated time points after axotomy were subjected to immunoblot
analysis.
(D) Axonal injury promotes interaction between AKT and MKK4. Cultures of sensory neurons were transduced with lentivirus expressing AKT1 with a C-terminal
HA-tag, and axonal proteins were subjected to anti-HA immunoprecipitation.
(E) Ser257/Thr261 and Ser78 phosphorylation can occur simultaneously onMKK4. HEK293 cells were transfected with plasmids expressingMKK4, together with
DLK or myrAKT1. Ser257/Thr261-phosphorylated MKK4 was immunoprecipitated by p-S257/T261-MKK4 specific antibody.
(legend continued on next page)
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after injury, over 60% of axons in the Cre-P2A-MKK4(S78A)
condition had already degenerated, and their degeneration
was completed by 72 hr (Figures 7E and 7F). Consistent with
Ser257/Thr261 and Ser78 phosphorylation being independent
events, MKK4flox/flox mice transduced with the Cre-P2A-
MKK4(WT) or Cre-P2A-MKK4(S78A) viruses exhibited similar
levels of Ser257/Thr261 phosphorylation after injury (Figures
7C and S6F). Our results demonstrate that MKK4 is regulated
by two distinct phosphorylation events in the early response
to axonal injury, and Ser78 phosphorylation mediated by a
Sarm1-independent AKT signal modulates the degeneration
process by limiting activation of downstream JNKs.
Involvement of the Sarm1-MAPK Pathway in Other
Axonal Insults
So far our study has focused on axon degeneration in models
of traumatic injury. To determine whether the Sarm1-MAPK
pathway participates in other types of axonal insult, we exam-
ined toxic effects of vincristine, a common chemotherapy drug,
and rotenone, a mitochondrial poison. Consistent with a previ-
ous report (Gerdts et al., 2013), Sarm1/ sensory axons were
resistant to vincristine toxicity. In addition, we observed that
combinatorial depletion of components at each level of the
MAPK cascade resulted in significant protection (Figure S7A).
Moreover, vincristine-damaged axons also exhibited local en-
ergy deficit before morphological degeneration in a Sarm1-
dependent manner (Figure S7B). Similarly, depletion of Sarm1
or components at each level of the MAPK cascade all protected
rotenone-damaged sensory axons against degeneration (Fig-
ure S7C), and rotenone-induced ATP depletion was partially
blocked in Sarm1/ axons (Figure S7D).
DISCUSSION
Although axonal death has been increasingly recognized as a
key pathological feature of neurodegenerative disorders, the
molecular mechanisms underlying the degeneration program
have been poorly characterized. In this study, we delineate a
MAPK cascade regulating pathological axon degeneration. Our
genetic analyses show that this MAPK cascade operates down-
stream of Sarm1, and likely represents the major downstream
signal mediated by Sarm1. Its pivotal role appears not to have
been fully appreciated because of the significant redundancy
at each level of the cascade. Interestingly, Sarm1-MAPK
signaling triggers a local energy deficit in injured axons, which
serves as the key functional link between the early degenerative
response of the Sarm1-MAPK pathway and the late phase of
morphological degeneration. Because the low level of cytosolic
Ca2+ in axons is maintained by Ca2+-ATPases and Na+/Ca2+-ex-
changers, both of which directly or indirectly depend on a con-
stant energy input, it appears plausible that energy deficit in(F and G) Ser78 phosphorylation inhibits MKK4 kinase activity toward JNK. HE
mutant with C-terminal HA-tag, together with DLK or myrAKT1. MKK4 proteins
assay (G) with recombinant GST-JNK3(K55R).
(H and I) MKK4 phosphorylation on Ser78 is independent of Sarm1 (H) or cytoNm
were harvested at indicated time points after axotomy for immunoblot analysis.
See also Figure S6.injured axons could result in gradual accumulation of cytosolic
Ca2+ which eventually activates calpains. Given the essential
role of ATP in cellular processes, this energy deficit might also
disrupt other vital functions in axons, which together with calpain
activation would lead to final breakdown of injured axons.
Various studies have supported the possibility that axon
degeneration in different pathological conditions could be under
a common regulatory mechanism. Therefore, the Sarm1-MAPK
pathway could play a critical role following axonal insults besides
traumatic injury. Indeed, our results with vincristine and rotenone
support that the signaling pathway from Sarm1 to the MAPK
cascade to axonal ATP depletion and to calpain-mediated
breakdown of axonal structures could be a commonmechanism
in different types of pathological axon degeneration. In this
context, it is interesting to note that JNK3 has been implicated
in the degeneration process in models of ischemic stroke
(Kuan et al., 2003), Huntington’s disease (Morfini et al., 2009),
and Alzheimer’s disease (Yoon et al., 2012), and a role for DLK
has also been reported in excitotoxicity-induced degeneration
(Pozniak et al., 2013). However, given the diversity of MAPK fam-
ily members, especially the MAPKKKs, it will be important to
determine whether additional MAPK member(s) are involved in
other types of axonal insults.
Future studies will also help elucidate the biochemical mech-
anism underlying Sarm1-mediated activation of the MAPK
cascade. In our initial studies we were unable to detect a direct
physical interaction between Sarm1, or its individual domains,
with components in the MAPK cascade (data not shown). In
addition, it will be critical to understand how the Sarm1-MAPK
pathway triggers local energy deficit in response to axonal
insults. Two pieces of evidence suggest that Sarm1-MAPK
signaling may disrupt a step(s) in glycolysis in axons: ATP deple-
tion in wild-type injured axons can be ameliorated by the glycol-
ysis end-product pyruvate (Figure 5C), and Sarm1/ axons can
maintain a fraction of their original ATP level even with ATP pro-
duction frommitochondria completely blocked by rotenone (Fig-
ure S7D). Of note, our findings on ATP depletion are consistent
with a previous report that examined axonal ATP (Wang et al.,
2005), but contrast with some others that examined ATP levels
in whole neuronal cultures, which included both axons and cell
bodies (Press and Milbrandt, 2008; Summers et al., 2014).
Because ATP measurements in this study were all performed
with pure axonal samples in absence of neuronal cell bodies,
our results provide a more direct insight into axon-specific
signaling events.
The protective cytoNmnat1/Wlds protein can inhibit activation
of the MAPK cascade upon injury. The mechanism underlying
cytoNmnat1/Wlds protective effect has been under debate,
and our finding opens an avenue to understanding how it inter-
sects with MAPK activation, either by altering nucleotide meta-
bolism or by additional mechanism(s). Since cytoNmnat1/WldsK293 cells were transfected with plasmids expressing MKK4 or MKK4(S78A)
were immunoaffinity-purified, then subjected to kinase assay (F) or pull-down
nat1 (I). Axonal proteins of cultured sensory neurons with indicated genotypes
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Figure 7. Antagonism of Pro-Degenerative Function of MKK4 by AKT Modulates the Early Response to Axonal Injury
(A) MKK4 phosphorylation on Ser78 in the early response to axonal injury in vivo. RGCs of wild-type orMKK4flox/floxmicewere subjected to saturated transduction
of Cre virus. Nerve samples were harvested at indicated time points after optic nerve crush for immunoblot analysis.
(B) mRNA expression of the 3members of the AKT family in adult mouse retina was determined by in situ hybridization. GCL, ganglion cell layer; INL, inner nuclear
layer; ONL, outer nuclear layer.
(C and D) MKK4 phosphorylation on Ser78 limits activation of downstream JNKs. RGCs of wild-type or MKK4flox/flox mice were subjected to saturated trans-
duction of indicated virus. Nerve sampleswere harvested at indicated time points after optic nerve crush for immunoblot analysis (C), and JNKphosphorylation on
Thr183/Tyr185 was quantified (D, n = 3 for each condition). Values are presented as mean ± SD.
(E and F) MKK4 phosphorylation on Ser78 modulates degeneration of injured RGC axons in vivo. RGCs of mice with indicated genotypes were transduced with
indicated viruses. Degeneration of TdTomato-positive axons was visualized at indicated time points after optic nerve crush (E), and degeneration was quantified
(F), n = 3 for each condition. Ai14 is the Rosa26-CAG-LSL-TdTomato reporter. Values are presented as mean ± SEM. *p < 0.01; n.s., not significant.
See also Figure S6.
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inhibits axon degeneration in many models of neurodegenera-
tion, it will also be exciting to determine whether its protective
effects in other degenerative paradigms rely on inhibition of the
MAPK pathway identified here.
It remains possible that AKT signaling also functions through
other targets to modulate axon degeneration. For instance, a
previous study reported that AKT could protect injured axons
by inhibiting GSK3b (Wakatsuki et al., 2011), although we found
that pharmacological inhibition of GSK3 in injured RGC axons
failed to significantly protect at least in vitro (Figures S6I and
S6J). With our finding that MKK4 is subject to the two tempo-
rally-distinct phosphorylation events, it is tempting to speculate
that activation of these two antagonizing signals could enable
pro-survival AKT to act immediately following injury to suppress
the MAPK degenerative response, allowing axons to repair
themselves if possible. Only when damage is irreversible would
the Sarm1-MAPK pathway instruct the destruction of injured
axons. Such a balance could represent an important checkpoint
to prevent inappropriate initiation of axon degeneration. It will
be of particular interest to explore whether reduction of AKT
signaling in axons, resulting in loss of this antagonistic mecha-
nism, contributes to axon degeneration in any disease condition.
In summary, our study demonstrates that distinct upstream
signals can converge onto a central MAPK pathway that triggers
local energy deficit to promote pathological axon degeneration
(Figure S7E), a regulatory mechanism with potentially broad im-
plications in neurodegenerative disease.EXPERIMENTAL PROCEDURES
Intravitreal Injection and Optic Nerve Injury
All surgical procedures in mice were performed in compliance with the proto-
col approved by the IACUC of the Rockefeller University. RGCs were
transduced by AAV2 (2 3 103 transduction units for sparse labeling; 1 3 107
transduction units for saturated labeling) delivered via intravitreal injection.
After 3 to 6 weeks, optic nerve crush was performed about 1 mm distal from
the eyeball. For visualization of TdTomato-labeled axons, nerve segments
about 2 mm proximal to the optic chiasm were scanned by confocal micro-
scopy. For biochemical analysis, nerve segments starting immediately distal
to the injury site up to the optic chiasm were dissected and homogenized in
150 ml Urea/SDS buffer (50 mM Tris-Cl [pH 6.8], 8 M urea, 10% SDS, 10 mM
sodium EDTA, and 50 mMDTT). Ten microgram of total protein for each nerve
sample was subjected to immunoblot analysis.
Neuronal Cultures and Analyses on Axonal Preparations
For RGC explant cultures, mouse retinas were dissected at post-natal day 1,
cut into 200 to 300 mm square explants, and cultured in growth factor-free me-
dium (Neurobasal medium supplemented with 2% B-27, 2 mM glutamine,
100 U/ml penicillin, 100 mg/ml streptomycin, 0.5% methyl-cellulose, and
0.75% glucose) with the RGC layer facing toward the culture surface coated
with poly-D-lysine/N-cadherin/fibronectin. Cultures of mouse embryonic
DRG neurons, embryonic cortical neurons, and post-natal SCG neurons
were as described (Osterloh et al., 2012). For biochemical analysis of axonal
samples, neuronal cell bodies and proximal axons were removed as described
(Yang et al., 2013). Axons were immediately quenched in 100%methanol pre-
cooled to 20C, then dissolved in Urea/SDS buffer. One microgram of total
protein for each condition pooled from 3 to 6 wells of cultures was subjected
to immunoblot analysis. For measurement of axonal ATP levels, neuronal cell
bodies and proximal axons were removed, and axons were lysed and sub-
jected to ATP measurement with the ATPlite Luminescence Assay System
(PerkinElmer). Four to six wells of cultures were included for each condition,
and results are presented as mean ± SEM.Quantification of Axon Degeneration
TdTomato-labeled axons in optic nerves or immunostained axons in cultures
were scored as degenerated with any sign of swelling and/or fragmentation.
Axons observed by electron microscopy in optic nerves were scored as de-
generated with any sign of demyelination and/or destruction of axoplasm.
Degeneration was quantified as the percentage of all axons scored as degen-
erated. Results are presented as mean ± SEM, and p value was calculated us-
ing a two-way ANOVA post hoc test.
In Situ Hybridization
Retinas from 8-week-old mice were dissected for 12 mm sagittal cryosections,
and sections were hybridized with digoxigenin-labeled antisense or sense
RNA probes (sequences available on request). Hybridized probes were de-
tected by alkaline phosphatase-conjugated anti-digoxigenin antibody (Roche)
and revealed by chromogenic substrate NBT/BCIP (Roche).
Experimental procedures including lentivirus production and transduction,
adeno-associated virus production, and electron microscopy have been pre-
viously described (Yang et al., 2013). The lentiviral-shRNA constructs from The
RNAi Consortium used in the study are listed in Table S1.
Information including antibodies and chemicals, and detailed procedures for
animal surgeries, neuronal cultures, immunohistochemistry, in situ hybridiza-
tion, kinase assay, and quantification methods are in Extended Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and one table and can be found with this article online at http://dx.doi.
org/10.1016/j.cell.2014.11.053.
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